Synthetic 'poop' can cure C. difficile infection, study finds
January 8, 2013 in Diseases, Conditions, Syndromes
A synthetic "poop" developed at the University of Guelph can cure nasty gastrointestinal infections caused by Clostridium difficile, a toxin-producing bacterium.
A study on the artificial stool was published today in the inaugural issue of Microbiome, a new peer-reviewed science journal.
The stool – a "super-probiotic" called RePOOPulate – was created by Guelph microbiologist Emma Allen-Vercoe to replace human fecal matter used in stool transplants, a known treatment for C. difficile.
She made the super-probiotic from purified intestinal bacterial cultures grown in "Robo-gut" equipment in a Guelph laboratory that mimics the environment of the large intestine.
Besides offering an effective therapy against the deadly superbug, the artificial poop is safer, more stable and adaptable, and less "icky" than treatments for C. difficile infection such as fecal bacteriotherapy, the study said.
"It's an exciting finding," said Allen-Vercoe, a professor in Guelph's Department of Molecular and Cellular Biology.
She worked on the project with lead researchers Dr. Elaine Petrof, an infectious disease specialist at Kingston General Hospital and a professor at Queen's University, and Gregory Gloor, a biochemistry professor at the University of Western Ontario. Guelph pathobiology professor Scott Weese and researcher Michelle Daigneault were also involved.
C. difficile can overpopulate the colon when antibiotics kill healthy gut bacteria. C. difficile infection causes many gastrointestinal problems, including severe diarrhea, and often leads to outbreaks in hospitals and long-term care facilities.
Few treatments exist for people with recurring C. difficile infections. Stool transplants are among the more effective therapies, but human fecal matter may contain unknown pathogens, Allen-Vercoe said. "That puts people at risk for future disease."
Stool transplants are also limited by lack of acceptance among patients and health-care facilities and lack of standardized treatment regimens.
Using synthetic poop for transplants eliminates the risk of transmitting an infectious disease through fecal bacteria because "the exact composition of the bacteria administered is known and can be controlled," Allen-Vercoe said.
The method may be modified to suit individual patient needs, is easily reproduced, and is more appealing to many patients and physicians, she said.
The researchers tested RePOOPulate on two patients with chronic C. difficile infections who had previously failed to respond to several rounds of antibiotics. After treatment with the synthetic poop, both were symptom-free within three days and tested negative for C. difficile six months later.
As well, later microbial profiles of both patients showed that some features of the synthetic stool stabilized in their colons. "In other words, the introduced microbes were able to persist," Allen-Vercoe said. "This is important because most commercially available probiotics only colonize transiently."
Allen-Vercoe hopes doctors will one day use the RePOOPulate concept to treat other GI conditions, such as inflammatory bowel disease, obesity and even autism by replacing abnormal gut microbial ecosystems.
Provided by
University of Guelph
-
Synthetic stool a prospective treatment for C. difficile
Apr 30, 2012 |
not rated yet |
0
-
Groundbreaking clinical trial looks at fecal transplant as treatment for C. difficile
Aug 21, 2012 |
not rated yet |
0
-
A new treatment option for Clostridium difficile: Fecal transplantation
Mar 14, 2012 |
not rated yet |
0
-
Study hints at probiotics as treatment for Clostridium difficile
Apr 20, 2011 |
not rated yet |
0
-
Dogs can accurately sniff out 'superbug' infections
Dec 13, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
No new H7N9 cases in China for a week
No new human cases of the H7N9 virus have been recorded in China for a week, national health authorities said, for the first time since the outbreak began in March.
Diseases, Conditions, Syndromes
1 hour ago |
not rated yet |
0
Nobel laureate plays down flu pandemic scaremongering
A Nobel prize-winning scientist Tuesday played down "shock-horror scenarios" that a new virus strain will emerge with the potential to kill millions of people.
Diseases, Conditions, Syndromes
1 hour ago |
5 / 5 (1) |
0
Resistance to last-line antibiotic makes bacteria resistant to immune system
Bacteria resistant to the antibiotic colistin are also commonly resistant to antimicrobial substances made by the human body, according to a study in mBio, the online open-access journal of the American Society for Microb ...
Diseases, Conditions, Syndromes
6 hours ago |
5 / 5 (1) |
0
Report: NPS hantavirus response followed policy
(AP)—Federal investigators probing the hantavirus outbreak blamed for three deaths at Yosemite National Park recommend that design changes to tent cabins and other lodging run by private concessionaires first be reviewed ...
Diseases, Conditions, Syndromes
12 hours ago |
not rated yet |
0
New test better detects elephantiasis worm infection
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...
Diseases, Conditions, Syndromes
13 hours ago |
not rated yet |
0
|
Biomarker trio predicts near-term heart risk
(Medical Xpress)—Cardiologists have identified a trio of biomarkers that may predict which patients with heart disease have a high risk of heart attack or death in the next two years.
Holding drivers' attention
Each day, an average of nine people are killed in the United States and more than 1,000 injured by drivers doing something other than driving.
New theory offers clues to vital 'repair and maintenance' role of sleep
(Medical Xpress)—We spend about a third of our life asleep, but why we need to do so remains a mystery. In a recent publication, researchers at University of Surrey and University College London suggest a new hypothesis, ...
Salt consumption in India: The need for data to initiate population-based prevention efforts
(Medical Xpress)—International researchers are studying the salt intake of Indian adults to provide vital new data to aid the development of a national salt reduction strategy.
Eyes on the sun: Child sunshine exposure and eye development
(Medical Xpress)—Exposure to sunshine as a small child is crucial to the development of a healthy eye according to results of long-term myopia study conducted by University of Sydney researchers.
Genetic predictors of postpartum depression uncovered
Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.
Jan 09, 2013
Rank: not rated yet